The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound ...

Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s ...

Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another ...

Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Sarepta Therapeutics, the bruised ...

Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several told ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Argenx said Monday it would buy ...

Casey’s reporting examines the use of artificial intelligence by providers and insurers. It is one of the oldest mysteries in medicine: Why do fundamentally healthy people drop dead? Sudden cardiac ...

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — The ...

Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.

Agios Pharmaceuticals is discontinuing the development of a next-generation drug called tebapivat for sickle cell disease. A ...

The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of ...